You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ado-Trastuzumab Emtansine

Showing 26 - 50 of 1,045
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

Recruiting
  • Brain Metastases
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 8, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in United States (trastuzumab-emtansine, Trastuzumab SC, Paclitaxel)

Recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Stamford, Connecticut
  • +16 more
Jun 20, 2022

Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F

Not yet recruiting
  • Breast Cancer
  • Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
  • Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
  • (no location specified)
Feb 22, 2023

Breast Cancer Trial in East Melbourne, Seoul (Placebo, Venetoclax, Trastuzumab emtansine)

Terminated
Has Results
  • Breast Cancer
  • Placebo
  • +2 more
  • East Melbourne, Victoria, Australia
  • +2 more
Oct 8, 2021

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago (drug, biological, other)

Completed
Has Results
  • HER2-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Chicago, Illinois
    Northwestern University
Jun 25, 2020

HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,

Not yet recruiting
  • HER2 Mutant Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Dec 6, 2022

Breast Cancer Trial in Houston, Sugar Land (T-DM1, Trastuzumab, Lapatinib)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

Recruiting
  • Non-small Cell Lung Cancer
  • London, United Kingdom
    Univeristy College London Hospital
Feb 22, 2022

HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

Recruiting
  • HER2+ Breast Cancer
  • Xi'an, Shaanxi, China
  • +1 more
Jun 20, 2022

Breast Tumors, Malignant Tumor of Breast Trial in Dallas (Trastuzumab, Ibrutinib 560 mg, Ibrutinib 840 mg)

Recruiting
  • Breast Neoplasms
  • Malignant Neoplasm of Breast
  • Dallas, Texas
    10 sites incl TX, WA, VA, and NV
May 16, 2022

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Advanced Cancer, Breast Cancer, Gastric Cancer Trial in Goodyear (Pembrolizumab, Trastuzumab, ado-trastuzumab emtansine)

Terminated
Has Results
  • Advanced Cancer
  • +4 more
  • Goodyear, Arizona
    Western Regional Medical Center/Cancer Treatment Center of Ameri
Oct 8, 2019

Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II Trial in Charlottesville (T-DM1, Capecitabine, External Beam

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Charlottesville, Virginia
    University of Virginia
Apr 12, 2022

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab Emtansine, Atezolizumab, Placebo)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab Emtansine
  • +2 more
  • Fountain Valley, California
  • +139 more
Aug 17, 2022

Metastatic Breast Cancer Trial in Spain (Palbociclib, Trastuzumab, Endocrine therapy)

Recruiting
  • Metastatic Breast Cancer
  • Badalona, Barcelona, Spain
  • +34 more
Oct 24, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Tumor Metastasis Trial in Worldwide (Docetaxel, Paclitaxel, Pertuzumab)

Recruiting
  • Neoplasm Metastasis
  • Duarte, California
  • +220 more
Aug 17, 2022

Tyrosine Kinase Inhibitors in Trastuzumab Emtansine Resistant

Recruiting
  • Breast Cancer
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Feb 7, 2022

Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +275 more
Dec 13, 2022

HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in India (Trastuzumab emtansine)

Completed
Has Results
  • HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer
  • Trastuzumab emtansine
  • New Delhi, Delhi, India
  • +12 more
Mar 31, 2021

HER2-positive Breast Cancer Trial in Worldwide (tucatinib, , T-DM1)

Recruiting
  • HER2-positive Breast Cancer
  • Mobile, Alabama
  • +262 more
Jan 26, 2023

Breast Cancer, Pregnancy Trial in Wilmington (Trastuzumab, Pertuzumab, Ado-Trastuzumab Emtansine)

Completed
  • Breast Cancer
  • Pregnancy
  • Wilmington, North Carolina
    Kendle International, Inc
May 15, 2019

Early Breast Cancer Trial in Worldwide (Trastuzumab and Pertuzumab (FDC SC) and T-DM1)

Recruiting
  • Early Breast Cancer
  • Trastuzumab and Pertuzumab (FDC SC) and T-DM1
  • Pleven, Bulgaria
  • +55 more
Jan 18, 2023

HER2-positive Breast Cancer Trial (Docetaxel, Carboplatin, Trastuzumab)

Not yet recruiting
  • HER2-positive Breast Cancer
  • (no location specified)
Jul 6, 2021